7774 — Japan Tissue Engineering Co Share Price
0.000.00%
Last trade - 00:00- ¥27bn
- ¥23bn
- ¥3bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.46 | ||
| Price to Tang. Book | 4.54 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 10.51 | ||
| EV to EBITDA | 1,362.22 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -2.35% | ||
| Return on Equity | -2.64% | ||
| Operating Margin | -5.57% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 2,309.85 | 2,257.61 | 2,103.44 | 2,032.45 | 2,514.19 | n/a | n/a | 1.29% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Japan Tissue Engineering Co Ltd is a Japan-based company mainly engaged in regenerative medicine product business, regenerative medicine outsourcing business, and research and development support business. The Company operates through three segments. The Regenerative Medicine Product segment develops regenerative medicine products using tissue engineering, and manufactures and sells the products for medical institutions. The regenerative medicine products include autologous cultured epidermis JACE, and autologous cultured cartilage JACK. The Regenerative Medicine Outsourcing segment provides contract development and manufacturing organization (CDMO) services, contract research organization (CRO) services, consulting services, and contract manufacturing services for specific cell processed products. The Research and Development Support segment manufactures and sells human cultured tissues that apply advanced culture technology accumulated through the development of in-house products.
Directors
- Kenichiro Hata PRE (54)
- Toshihiro Ohsuka SME (64)
- Masahito Ohbayashi EXO (64)
- Masukazu Inoie EXO
- Toru Kuroda EXO (58)
- Yukio Mori EXO (60)
- Tsutomu Tezuka IND (66)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 1st, 1999
- Public Since
- December 21st, 2007
- No. of Shareholders
- 10,652
- No. of Employees
- 211
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 40,609,950
- Address
- 6-209-1, Miyakita-dori, GAMAGORI-SHI, 443-0022
- Web
- https://www.jpte.co.jp/
- Phone
- +81 533662020
- Auditors
- KPMG AZSA LLC
Upcoming Events for 7774
Similar to 7774
Alfresa Holdings
Tokyo Stock Exchange
Asahi Intecc Co
Tokyo Stock Exchange
Aso International
Tokyo Stock Exchange
As One
Tokyo Stock Exchange
Atect
Tokyo Stock Exchange
FAQ
What is the Japan Tissue Engineering Co share price?
As of Today at 21:28 UTC, shares in Japan Tissue Engineering Co are trading at ¥630. This share price information is delayed by 15 minutes.
How has the Japan Tissue Engineering Co share price performed this year?
Shares in Japan Tissue Engineering Co last closed at ¥630 and the price had moved by -2.93% over the past 365 days. In terms of relative price strength the Japan Tissue Engineering Co share price has outperformed the Nikkei 225 Index by +2.3% over the past year.
What are the analyst and broker recommendations for Japan Tissue Engineering Co?
The overall consensus recommendation for Japan Tissue Engineering Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Japan Tissue Engineering Co dividend yield?
Japan Tissue Engineering Co does not currently pay a dividend.
Does Japan Tissue Engineering Co pay a dividend?
Japan Tissue Engineering Co does not currently pay a dividend.
When does Japan Tissue Engineering Co next pay dividends?
Japan Tissue Engineering Co does not currently pay a dividend.
How do I buy Japan Tissue Engineering Co shares?
To buy shares in Japan Tissue Engineering Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Japan Tissue Engineering Co?
As of the previous close price of ¥630, shares in Japan Tissue Engineering Co had a market capitalisation of ¥27bn.
Where are Japan Tissue Engineering Co shares listed?
Here are the trading details for Japan Tissue Engineering Co:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 7774
What kind of share is Japan Tissue Engineering Co?
Based on an overall assessment of its quality, value and momentum Japan Tissue Engineering Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Japan Tissue Engineering Co share price forecast for 2025?
The analyst consensus target price for shares in Japan Tissue Engineering Co is ¥1,154. That is 83.21% above the last closing price of ¥630.
Analysts covering Japan Tissue Engineering Co currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Japan Tissue Engineering Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Japan Tissue Engineering Co. Over the past six months, its share price has outperformed the Nikkei 225 Index by +39.01%.
As of the last closing price of ¥630, shares in Japan Tissue Engineering Co were trading +21.41% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Japan Tissue Engineering Co PE Ratio?
The Japan Tissue Engineering Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥630.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Japan Tissue Engineering Co?
Japan Tissue Engineering Co's management team is headed by:
- Kenichiro Hata - PRE
- Toshihiro Ohsuka - SME
- Masahito Ohbayashi - EXO
- Masukazu Inoie - EXO
- Toru Kuroda - EXO
- Yukio Mori - EXO
- Tsutomu Tezuka - IND